<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02591563</url>
  </required_header>
  <id_info>
    <org_study_id>CIC 1141 B-09-1</org_study_id>
    <nct_id>NCT02591563</nct_id>
  </id_info>
  <brief_title>Evaluate Pathogens and Immunity to Acute Otitis Media in Healthy Children.</brief_title>
  <acronym>AOM</acronym>
  <official_title>A Study Evaluating Pathogens and Immunity to Acute Otitis Media and Nasopharyngeal Colonization in Healthy Children.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rochester General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rochester General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to Evaluate Pathogens and Immunity to Acute Otitis Media in
      Healthy Children.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective evaluation of bacterial pathogens Streptococcus. pneumoniae, Haemophilus
      influenzae, Moraxella. catarrhalis and Staphylococcus aureus and their antibiotic
      susceptibility when colonizing the nasopharynx and/or causing acute otitis media in the years
      2015-2025. The goal will be to recruit children into a prospective group beginning at 6
      months of age and followed to 36 months of age in suburban Rochester, New York.
      Nasopharyngeal and nasal wash samples will be obtained at each well child visit and at acute
      otitis media (AOM) episodes. Middle ear fluid will be obtained from every child with an acute
      otitis media episode who undergoes a tympanocentesis procedure. All of the nasopharyngeal and
      middle ear fluid samples collected will be tested by standard microbiologic techniques to
      identify the presence of 4 potential otopathogens (S. pneumoniae, H. influenzae, M.
      catarrhalis and S. aureus). All S. pneumoniae will undergo serotyping and antibiotic
      susceptibility testing. All samples that are culture negative will be evaluated with a
      multi-locus PCR test to examine for presence of potential otopathogens.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The distribution of bacteria causing acute otitis media.</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The distribution of potential otopathogens colonizing the nasopharynx.</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Nasopharyngeal Colonization and Acute Otitis Media</condition>
  <arm_group>
    <arm_group_label>Healthy children</arm_group_label>
    <description>6-36 months of age who will have the following study procedures: Venipuncture, Nasopharyngeal swab, nasopharyngeal wash, tympanocentesis</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>procedures</intervention_name>
    <description>Nasopharyngeal swab, nasopharyngeal wash, tympanocentesis (if acute otitis media occurs), venipuncture</description>
    <arm_group_label>Healthy children</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      middle ear fluid, nasal swabs, nasal wash, and blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy 6-36 month old children or Acute Otitis Media diagnosed children &gt;/= 6mo but &lt;/= 36
        months
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Healthy Children:

          -  Male or female age greater than/equal to 6 months or less than/equal to 36 months old.

          -  Parent/guardian willing to bring to all study visits

        Exclusion Criteria:

          -  Any major illness/condition that in investigator opinion would put subject at risk
             during study.

          -  Otorrhea or tympanostomy tubes present in either ear @ time of enrollment.

          -  Direct descendant of study site personnel.

          -  Subjects &lt; 6 months old or &gt;36 months old at the time of enrollment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>36 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael E Pichichero, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rochester General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael E Pichichero, MD</last_name>
    <phone>585-922-5959</phone>
    <email>michael.pichichero@rochesterregional.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rochester General Hospital</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14621</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Colleen Wicks, LPN</last_name>
      <email>colleen.wicks@rochesterregional.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>October 28, 2015</study_first_submitted>
  <study_first_submitted_qc>October 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 29, 2015</study_first_posted>
  <last_update_submitted>December 17, 2019</last_update_submitted>
  <last_update_submitted_qc>December 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rochester General Hospital</investigator_affiliation>
    <investigator_full_name>Michael Pichichero</investigator_full_name>
    <investigator_title>MD, Director, Rochester General Hospital Research Institute</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Otitis</mesh_term>
    <mesh_term>Otitis Media</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

